Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.590
+0.020 (1.27%)
Dec 20, 2024, 4:00 PM EST - Market closed
Werewolf Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 71 | 140 | 63 | 328 | - | - |
| Market Cap Growth | 21.41% | 121.66% | -80.81% | - | - | - |
| Enterprise Value | -15 | 62 | -62 | 160 | - | - |
| Last Close Price | 1.59 | 3.86 | 2.05 | 11.91 | - | - |
| PS Ratio | 19.42 | 7.01 | 3.84 | - | - | - |
| PB Ratio | 0.78 | 1.25 | 0.52 | 2.15 | - | - |
| P/TBV Ratio | 1.04 | 1.25 | 0.52 | 2.15 | - | - |
| EV/Sales Ratio | - | 3.10 | - | - | - | - |
| Debt / Equity Ratio | 0.41 | 0.47 | 0.12 | 0.10 | 0.03 | 0.32 |
| Asset Turnover | 0.02 | 0.12 | 0.10 | - | - | - |
| Quick Ratio | 9.89 | 7.00 | 5.68 | 13.27 | 17.52 | 8.76 |
| Current Ratio | 10.10 | 7.14 | 5.84 | 13.56 | 17.58 | 8.84 |
| Return on Equity (ROE) | -61.56% | -31.98% | -39.12% | -41.31% | -30.39% | - |
| Return on Assets (ROA) | -26.15% | -15.11% | -20.64% | -22.71% | -23.72% | - |
| Return on Capital (ROIC) | -28.46% | -16.86% | -22.94% | -24.06% | -26.76% | - |
| Earnings Yield | -87.67% | -26.75% | -85.38% | -15.22% | - | - |
| FCF Yield | -66.12% | -23.89% | -70.14% | -13.20% | - | - |
| Buyback Yield / Dilution | -20.96% | -23.50% | -56.40% | -1736.32% | -57.27% | - |
| Total Shareholder Return | -20.96% | -23.50% | -56.40% | -1736.32% | -57.27% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.